EP2283825
Enteric solid oral dosage form of a bisphosphonate containing a chelating agent
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.4.2005EP published:
13.4.2022EP application number:
10011938.7
EPO information:
European Patent Register
Max expiry date:
13.4.2025
Title in English:
Enteric solid oral dosage form of a bisphosphonate containing a chelating agentLanguage of the patent:
English
Timeline
Today
14.4.2005EP application
13.4.2022EP Publication
Owner
Name:
Allergan Pharmaceuticals International LimitedAddress:
Clonshaugh Industrial Estate Coolock, Dublin 17, IE
Name:
Theramex HQ UK LimitedAddress:
Sloane Square House 1 Holbein Place, Belgravia Greater London SW1W 8NS, GB
Inventor
Name:
Dansereau, Richard JohnAddress:
Cincinnati, OH 45208, US
Name:
Burgio, Ernest David, Jr.Address:
Liberty Township, OH 45011, US
Priority
Number:
573881 PDate:
24.5.2004Country:
US
Classification
Categories:
A61K 9/20, A61K 31/675, A61K 31/00, A61K 9/28